|
|
Catalyst Pharmaceutical Partners (CPRX) |
StreetInsider.com
May 16
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Catyalyst+Pharmaceutical+%28CPRX%29+Posts+Narrower+than+Expected+Q1+Loss/8345851.html for the full story.
StreetInsider.com
Apr 2
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Catyalyst+Pharmaceutical+Partners+%28CPRX%29+Posts+Better+than+Expected+Q4+Loss/8224078.html for the full story.
Benzinga
Mar 5
Comment
Catalyst Pharmaceutical
Partners, Inc. (Nasdaq: CPRX), a specialty pharmaceutical company focused on
the development and commercialization of novel prescription drugs targeting
rare (orphan) neurological diseases and disorders, is pleased to...
StreetInsider.com
Feb 11
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Catyalyst+%28CPRX%29+Updates+on+Pipeline%3B+Sees+Filling+NDA+for+Firdapse+After+Q115/8077223.html for the full story.
Benzinga
Dec 27
Comment
Catalyst Pharmaceutical
Partners, Inc. (Nasdaq: CPRX) announced today that it received a Nasdaq Staff
Deficiency Letter, dated December 24, 2012, indicating that the Company is not
in compliance with the Minimum Bid Price requirement set forth in...
StreetInsider.com
Nov 15
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Catyalyst+Pharmaceutical+Partners+%28CPRX%29+Reports+Q3+Loss+of+%240.08/7881778.html for the full story.
StreetInsider.com
Nov 8
Comment
Catyalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX) 61.5% LOWER; announced top-line results from its U.S. Phase II(b) clinical trial evaluating the use of CPP-109 (vigabatrin) to treat cocaine addiction. The data from the trial showed that...
FierceBiotech
Nov 8
Comment
Catalyst Pharmaceutical Partners ($CPRX) says that its cocaine addiction therapy flopped in a Phase IIb study, missing primary and secondary endpoints and triggering a collapse in its share price, which tumbled 65% on the news.
The small Coral...
StreetInsider.com
Nov 8
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Catyalyst+%28CPRX%29+Says+CPP-109+Missed+Phase+IIb+Primary+Endpoint/7856489.html for the full story.
StreetInsider.com
Oct 31
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Catalyst+%28CPRX%29%2C+BioMarin+%28BMRN%29+Enter+Firdapse+Collaboration/7830096.html for the full story.
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS|
Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png': No such file or directory @ blob.c/OpenBlob/2480. convert: unable to open file `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png' @ png.c/ReadPNGImage/2889. convert: missing an image filename `/home/wikinvest/src_live_2/mediawiki/images/thumb/9/98/New_stock.png/35px-New_stock.png' @ convert.c/ConvertImageCommand/2800. |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
